Clinical Trials Browser

Not yet recruiting × OTHER × Recurrence × Clear all

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07532746 2026-04-16

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

Phase 1 Not yet recruiting

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT07493174 2026-04-15

Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies

Phase 1 Not yet recruiting

Recurrence

NCT07521670 2026-04-13

STRAP

Phase 2 Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT07519187 2026-04-09

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

Phase EARLY_PHASE1 Not yet recruiting

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Phase EARLY_PHASE1 Not yet recruiting

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07502768 2026-03-31

EpiRev-NKT

Phase 1/2 Not yet recruiting

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT07484763 2026-03-20

Predicting Recurrence in HR+/HER2- Early Breast Cancer

Not yet recruiting

Breast Neoplasms, Recurrence

NCT07478705 2026-03-17

EINSTEIN-TNBC

Phase NA Not yet recruiting

Recurrence, Triple Negative Breast Neoplasms

NCT06639607 2026-03-10

PRiME II

Phase 1/2 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT07458204 2026-03-09

EPPIL

Phase 2 Not yet recruiting

Recurrence, Triple Negative Breast Neoplasms

NCT07453095 2026-03-05

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

Phase 2 Not yet recruiting

Recurrence, Lymphoma, Mantle-Cell

NCT07448376 2026-03-04

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT07444918 2026-03-03

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Phase 2 Not yet recruiting

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07428486 2026-02-23

A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07423104 2026-02-20

A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia

Phase 2 Not yet recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT07424092 2026-02-20

PED-DNX2401

Phase 2 Not yet recruiting

Ependymoma, Glioma, Recurrence

NCT07424664 2026-02-20

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

NCT07234721 2026-02-10

SL4903

Phase EARLY_PHASE1 Not yet recruiting

Multiple Myeloma, Recurrence

NCT07198945 2026-02-04

STARLING

Phase NA Not yet recruiting

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps, Neoplasm Recurrence, Local, Recurrence

NCT07286162 2026-01-27

CALM-TF

Phase 3 Not yet recruiting

Ovarian Neoplasms, Recurrence

NCT07363330 2026-01-26

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT07350824 2026-01-20

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

Phase NA Not yet recruiting

Recurrence, Neoplasm, Residual

NCT07345741 2026-01-16

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Not yet recruiting

Recurrence, Lymphoma, B-Cell

NCT07348393 2026-01-16

Mezi-KD

Phase 2 Not yet recruiting

Multiple Myeloma, Recurrence

NCT07343934 2026-01-15

huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma

Phase 1 Not yet recruiting

Lymphoma, Follicular, Recurrence

NCT07340164 2026-01-14

TROY

Phase 2 Not yet recruiting

Ovarian Neoplasms, Recurrence

NCT07330895 2026-01-09

Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors

Phase EARLY_PHASE1 Not yet recruiting

Recurrence

NCT07331064 2026-01-09

GABRIEL

Phase 1 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma, Recurrence, Rhabdoid Tumor

NCT07277777 2026-01-06

125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors

Phase 2 Not yet recruiting

Neoplasms, Recurrence

NCT07316920 2026-01-06

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Phase 1 Not yet recruiting

Recurrence, Lymphoma, B-Cell

NCT07319793 2026-01-06

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Phase NA Not yet recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT07316907 2026-01-05

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Hematologic Neoplasms

NCT07166549 2025-12-24

BaseCAR-01

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07288814 2025-12-17

Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

Phase 1/2 Not yet recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Phase 1/2 Not yet recruiting

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT07200479 2025-10-01

A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms

Phase 1 Not yet recruiting

Recurrence

NCT07198451 2025-09-30

GEM-IR-NMIBC

Phase 2/3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT07175415 2025-09-16

HEM-iSMART E

Phase 1/2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Phase EARLY_PHASE1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07113496 2025-08-13

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Phase 1 Not yet recruiting

LymphoidPlasma cell

Plasmablastic Lymphoma, Burkitt Lymphoma, Multiple Myeloma, Recurrence

NCT07097948 2025-08-01

Adjuvant

Phase 2 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT07098949 2025-08-01

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

Phase NA Not yet recruiting

Gastrointestinal

Recurrence, Stomach Neoplasms

NCT07077330 2025-07-22

CAR19BCMA

Phase EARLY_PHASE1 Not yet recruiting

Recurrence, Neoplasms, Plasma Cell

NCT07077798 2025-07-22

Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT06993506 2025-05-29

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Not yet recruiting

Neoplasm Metastasis, Recurrence

NCT06982690 2025-05-21

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

Phase NA Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Recurrence

NCT04275102 2025-05-15

Three Times Weekly Symptom Screening for Children With Cancer

Phase NA Not yet recruiting

Neoplasms, Recurrence

NCT06880601 2025-04-03

TALIM

Phase 2 Not yet recruiting

Multiple Myeloma, Recurrence

NCT06788600 2025-04-02

WGc-043

Not yet recruiting

Lymphoma, Recurrence